Advanced Targeted Treatment for Peritoneal Surface Malignancies
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) are innovative treatment options designed for cancers that have spread to the peritoneum, the lining of the abdominal cavity. These advanced therapies deliver chemotherapy directly into the abdomen, targeting cancer cells more effectively while minimizing systemic side effects.
At our center, we offer comprehensive evaluation and personalized treatment plans utilizing the latest advances in peritoneal surface oncology. Our multidisciplinary team combines surgical expertise, medical oncology, and supportive care to provide the best possible outcomes for patients with complex abdominal cancers...
What Is HIPEC?
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a specialized procedure performed immediately after Cytoreductive Surgery (CRS). Once all visible tumors have been removed, a heated chemotherapy solution is circulated throughout the abdominal cavity.
The combination of heat and direct chemotherapy delivery helps:
Destroy microscopic cancer cells that may remain after surgery
Improve chemotherapy penetration into tissues
Reduce the risk of cancer recurrence within the abdomen
Deliver high concentrations of chemotherapy directly to affected areas
HIPEC is commonly used in carefully selected patients with peritoneal surface malignancies...
What Is PIPAC?
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a minimally invasive procedure that delivers chemotherapy as a pressurized aerosol into the abdominal cavity using laparoscopic techniques.
This innovative approach offers several advantages:
Enhanced distribution of chemotherapy throughout the peritoneal cavity
Improved tissue penetration
Minimally invasive treatment through small incisions
Shorter recovery times compared to major surgery
Can be repeated at scheduled intervals when clinically appropriate
PIPAC may be considered for patients with advanced peritoneal metastases who are not candidates for extensive cytoreductive surgery or require additional disease control...
Conditions Treated with HIPEC and PIPAC
These advanced therapies may be recommended for:
Peritoneal carcinomatosis
Colorectal cancer with peritoneal metastases
Ovarian cancer with peritoneal spread
Appendiceal cancers
Pseudomyxoma peritonei (PMP)
Peritoneal mesothelioma
Gastric cancer with selected peritoneal involvement
Other carefully selected abdominal cancers
Each patient undergoes a detailed assessment to determine the most appropriate treatment strategy...
Benefits of HIPEC
Direct delivery of chemotherapy to the abdominal cavity
Higher local drug concentration with reduced systemic exposure
Enhanced effectiveness through heat-assisted chemotherapy
Treatment of microscopic residual disease
Potential improvement in long-term disease control and survival
Performed during a single surgical procedure following CRS...
Benefits of PIPAC
Minimally invasive treatment option
Enhanced chemotherapy distribution and penetration
Reduced recovery time
Repeatable treatment sessions if required
Symptom control and improved quality of life in selected patients
Suitable for certain patients with advanced or unresectable disease..
Why Choose Us?
Expertise in CRS, HIPEC, and PIPAC procedures
Specialized management of peritoneal surface malignancies
Advanced surgical oncology and minimally invasive techniques
Multidisciplinary cancer care approach
Comprehensive diagnostic and treatment planning
Personalized care tailored to each patient's needs
State-of-the-art facilities and technology...
Schedule a Consultation
If you have been diagnosed with peritoneal cancer or cancer that has spread within the abdominal cavity, our specialists can help determine whether HIPEC or PIPAC may be suitable for your condition. Contact us today to schedule a consultation and learn more about advanced treatment options designed to improve outcomes and quality of life....
BOOK APPOINTMENT